TENAZYM
TENAZYM
Authorised
- Chymotrypsin
- NEOMYCIN SULFATE
- Papain
- Prednisolone acetate
- Tetracycline hydrochloride
- Trypsin
Product identification
Medicine name:
TENAZYM
Active substance:
- Chymotrypsin
- NEOMYCIN SULFATE
- Papain
- Prednisolone acetate
- Tetracycline hydrochloride
- Trypsin
Target species:
-
Cat
-
Dog
Route of administration:
-
Cutaneous use
-
Oral use
Product details
Active substance and strength:
-
Chymotrypsin0.40/milligram(s)1.00millilitre(s)
-
NEOMYCIN SULFATE22.50/milligram(s)1.00millilitre(s)
-
Papain1.00/milligram(s)1.00millilitre(s)
-
Prednisolone acetate2.00/milligram(s)1.00millilitre(s)
-
Tetracycline hydrochloride30.00/milligram(s)1.00millilitre(s)
-
Trypsin0.40/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01RV
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Romania
Package description:
- Available only in Romanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Veyx Pharma GmbH
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 120112
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Romanian (PDF)
Published on: 25/10/2021